CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 31 enrolled
Drug / intervention
Counseling and active drug intervention +2 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03416621
NCT03416621Phase 3Completed
CompareCT.gov

Project Q Pilot: Examining Different Treatment Modalities to Maximize Cessation Efforts for Light Smokers

Duke University·interventional·Posted Jan 31, 2018·Updated Mar 29, 2021

In Brief

A Phase 3 clinical trial evaluating Cognitive behavioral cessation counseling, Counseling and placebo drug intervention, and 1 other intervention for Tobacco Use Cessation. Completed, enrolled 31 participants across 1 site.

Detailed Summary

The purpose of this pilot study is to evaluate the feasibility, acceptability, and preliminary efficacy of an intervention to promote smoking cessation among light smokers.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsTobacco Use Cessation
CountriesUnited States
Collaborators--

Timeline

Phase 3CompletedFinished
201820192020202120222023202420252026
First PostedJan 31, 2018
Enrollment StartMay 17, 2018
Primary CompletionFeb 29, 2020
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 8.4 years ago

Interventions

Cognitive behavioral cessation counselingbehavioral

Standard smoking cessation plus support text messages

Counseling and placebo drug interventionbehavioral

Enhanced cue exposure treatment (lab-based + interactive SMS texting) + DCS placebo

Counseling and active drug interventiondrug

Enhanced cue exposure treatment (lab-based + interactive SMS texting)+ active DCS. In addition to an in-person, screening visit, we will conduct three in-person treatment visits and an in-person follow-up visit.